Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation

Carcinogenesis
Eun Mi JungTaeg Kyu Kwon

Abstract

Death receptor DR5 (DR5/TRAIL-R2) is an apoptosis-inducing membrane receptor for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). In this study, we showed that curcumin, a plant product containing the phenolic phytochemical, is a potent enhancer of TRAIL-induced apoptosis through upregulation of DR5 expression. Both treatment with DR5/Fc chimeric protein and silencing of DR5 expression using small interfering RNA (siRNA) attenuated curcumin plus TRAIL-induced apoptosis, showing that the critical role of DR5 in this cell death. Curcumin also induced the expression of a potential pro-apoptotic gene, C/EBP homologous protein (CHOP), both at its mRNA and protein levels. However, suppression of CHOP expression by small interfering RNA did not abrogate the curcumin-mediated induction of DR5 and the cell death induced by curcumin plus TRAIL, demonstrating that CHOP is not involved in curcumin-induced DR5 upregulation. Taken together, the present study demonstrates that curcumin enhances TRAIL-induced apoptosis by CHOP-independent upregulation of DR5.

Citations

Jun 25, 2009·Cancer Immunology, Immunotherapy : CII·Peter Hersey, Xu Dong Zhang
Jan 11, 2007·Journal of Clinical Immunology·Ganesh Chandra Jagetia, Bharat B Aggarwal
Feb 16, 2010·Nutrition and Cancer·Bhaumik B Patel, Adhip P N Majumdar
May 6, 2010·Molecular Cancer Therapeutics·Karuppaiyah SelvendiranPeriannan Kuppusamy
Jul 11, 2009·The AAPS Journal·Jayaraj RavindranBharat B Aggarwal
Mar 1, 2012·The Korean Journal of Thoracic and Cardiovascular Surgery·Jong In KimHae Young Lee
Mar 5, 2013·Annual Review of Plant Biology·Cathie MartinKatia Petroni
May 29, 2010·Cellular and Molecular Life Sciences : CMLS·Guillaume JacqueminOlivier Micheau
Dec 10, 2009·Molecular Aspects of Medicine·Gregory MellierShazib Pervaiz
Jan 2, 2009·Cancer Treatment Reviews·Devalingam MahalingamAfshin Samali
Jul 25, 2007·Current Problems in Cancer·Shishir ShishodiaBharat B Aggarwal
Sep 22, 2012·BioFactors·Shishir Shishodia
May 9, 2012·Free Radical Research·Gregory Mellier, Shazib Pervaiz
Dec 19, 2012·Biochimica Et Biophysica Acta·Seoung Woo Shin, Jeen-Woo Park
Aug 11, 2007·Bioscience, Biotechnology, and Biochemistry·Shyuichiro InagakiKenji Kida
Jul 28, 2016·Experimental Cell Research·Minami KumazakiYukihiro Akao
Jan 12, 2017·Journal of Cellular Physiology·Mahin RamezaniAmirhosein Sahebkar
Apr 28, 2011·Experimental Biology and Medicine·Konstantinos ArgirisMahvash Tavassoli
Aug 5, 2018·Journal of Cellular Physiology·Mahdi HatamipourAmirhosein Sahebkar
Jan 10, 2019·Journal of Cellular Physiology·Keywan MortezaeeAmirhossein Sahebkar
Jun 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jun-Jie ChenChing-Chow Chen
Sep 6, 2018·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Ran Hong, Song Iy Han
Oct 26, 2016·International Journal of Oncology·Sung-Chul LimSong Iy Han
Mar 7, 2020·Pharmacological Reports : PR·Sridevi SurapallyRama Shanker Verma
Jul 28, 2019·Journal of Cellular Physiology·Mahdi HatamipourAmirhossein Sahebkar
Dec 12, 2020·Nutrition and Cancer·Connor ChestnutShrikant Anant

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis